Literature DB >> 31415344

Concentration of Physician Services Across Insurers and Effects on Quality: Early Evidence From Medicare Advantage.

W Pete Welch1, Aditi P Sen2, Andrew B Bindman3.   

Abstract

BACKGROUND: A growing proportion of Medicare beneficiaries is covered by private insurers through Medicare Advantage, yet little is known about how these plans are structured in terms of relationships with physicians and implications for quality of care.
OBJECTIVE: The objective of this study was to assess whether greater physician concentration of services across insurers was associated with higher quality in Medicare Advantage (MA), overall and particularly among MA insurers serving a high proportion of vulnerable enrollees. RESEARCH
DESIGN: A retrospective cohort design with regression analysis. DATA SOURCES: The primary dataset was 2014 MA encounter records submitted by insurers to the Centers for Medicare and Medicaid Services, covering 600,329 physicians across 119 insurers. These data were merged with Centers for Medicare and Medicaid Services data on MA contract quality rating as well as physician characteristics in the Medicare Data on Provider Practice and Specialty file. MEASURES: Two measures were generated to capture the concentration of physician services across insurers: the percentage of a physician's Medicare services which was through MA (MA penetration); and the percentage of a physician's MA services with a specific insurer (insurer share of MA services).
RESULTS: Greater MA penetration and insurer share of MA services were each associated with higher MA plan quality. The relationship between insurer share and quality was stronger in contracts with a relatively high percentage of disabled enrollees.
CONCLUSION: Greater physician concentration of services across MA insurers was associated with a higher quality of care overall and especially among vulnerable enrollees.

Mesh:

Year:  2019        PMID: 31415344     DOI: 10.1097/MLR.0000000000001193

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  3 in total

1.  Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare.

Authors:  Kelly E Anderson; Daniel Polsky; Sydney Dy; Aditi P Sen
Journal:  Health Serv Res       Date:  2021-12-14       Impact factor: 3.734

2.  Can Understanding Outcomes for Medicare Advantage Enrollees Reduce Racial and Ethnic Disparities in Kidney Disease?

Authors:  Keith C Norris
Journal:  Am J Nephrol       Date:  2021-12-07       Impact factor: 3.754

Review 3.  Medicare Advantage Chart Reviews Are Associated With Billions in Additional Payments for Some Plans.

Authors:  David J Meyers; Amal N Trivedi
Journal:  Med Care       Date:  2021-02-01       Impact factor: 3.178

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.